Showing results (431-440 of 5,672) with videos related to
Sort By:
Pageof 568
The Oncologist|October 5, 2007
A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effectsScott E Strome, Edward A Sausville, Dean MannThe Oncologist|October 5, 2007
Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experienceFrank Mayer, Hermann Aebert, Maximilian Rudert, et al.The Oncologist|October 5, 2007
Randomized crossover pharmacokinetic evaluation of subcutaneous versus intravenous granisetron in cancer patients treated with platinum-based chemotherapyAlfonso Gurpide, Belen Sadaba, Salvador Martin-Algarra, et al.The Oncologist|July 1, 2008
Pediatric central nervous system germ cell tumors: a reviewMaria E Echevarría, Jason Fangusaro, Stewart GoldmanThe Oncologist|July 1, 2008
FDA drug approval summary: nelarabine (Arranon) for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Robert Justice, et al.The Oncologist|August 13, 2008
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?William R Miller, John Bartlett, Angela M H Brodie, et al.The Oncologist|August 15, 2008
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapyEvelien L J M Smits, Peter Ponsaerts, Zwi N Berneman, et al.The Oncologist|November 21, 2008
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapyJörg Dietrich, Michelle Monje, Jeffrey Wefel, et al.The Oncologist|November 15, 2008
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with tremelimumab (CP-675,206)Antoni RibasThe Oncologist|November 15, 2008
Overcoming immunologic tolerance to melanoma: targeting CTLA-4 with ipilimumab (MDX-010)Jeffrey WeberPageof 568